Here are four things to know.
1. At present, the FDA has approved seven biosimilar drugs, which are highly similar versions of biologic drugs.
“As more biosimilars are approved by FDA, we want healthcare providers to understand what these drugs are, and how they can help patients,” FDA commissioner Scott Gottlieb, MD, and Leah Christl, PhD, associate director for therapeutic biologics in the agency’s Office of New Drugs, wrote in the post.
2. The FDA conducted extensive research and learned what questions providers had about biosimilars before developing educational materials for the campaign.
3. Resources include fact sheets and informational graphics for providers that:
- Define terms like “biological product” and “interchangeable” to clarify the relationship between biosimilars and their reference products
- Describe the regulatory pathway for biosimilars to earn approval and highlight the rigorous standards they must meet
- Provide information on what data the agency reviews to determine biosimilarity to the reference product.
4. The FDA believes biosimilars may reduce costs for patients and the U.S. healthcare system by achieving more market competition.
“As with the significant savings that we’ve seen through the introduction of generic drugs in the United States, biosimilars could also lead to substantial savings, thereby potentially improving access and promoting better public health outcomes,” Drs. Gottlieb and Christl concluded.
More articles on supply chain:
Woman finds pile of ‘hundreds’ of expired medical supplies outside Dallas hospital
FDA issues warning letter to Magellan over violations related to blood-lead tests
Novartis receives breakthrough designation from FDA for melanoma drug
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
